Boston Scientific Corp.
BSX
Key stats
- Open
- 45.40
- Day high
- 45.60
- Day low
- 43.79
- Previous close
- 45.13
- Volume
- 11.51M
- VWAP
- 44.33
- 52-week high
- 105.65
- 52-week low
- 39.57
- Market cap
- 65.41B
- Shares out
- 1.45B
- Employees
- 59,000
- Listed
- 1992
About Boston Scientific Corp.
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · MARLBOROUGH, MA · bostonscientific.com
Options · expiring Nov 13
Nov 12, 4:00 PM ET- Call open interest
- 7.7K
- Put open interest
- 4.0K
- Put/call
- 0.52
- At-the-money IV
- 20.6%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 45 call | 0.10 | Nov 12, 2:53 PM | 176 | 1.3K | 20.6% |
| 42.50 put | 0.06 | Nov 12, 12:04 PM | 141 | 123 | 80.2% |
| 47 put | 2.50 | Nov 12, 3:19 PM | 103 | 68 | 154.3% |
| 46 call | 0.05 | Nov 12, 2:03 PM | 70 | 532 | 46.4% |
| 43 put | 0.08 | Nov 12, 3:26 PM | 61 | 328 | 73.4% |
| 43.50 put | 0.17 | Nov 12, 3:06 PM | 61 | 69 | 71.4% |
Quarterly results
Massive · Nov 2, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $5.14B | $5.44B | $5.20B | $5.29B |
| Gross profit | $3.43B | $3.85B | $3.61B | $3.68B |
| Operating income | $828.00M | $1.18B | $1.10B | $825.00M |
| Net income | $582.00M | $907.00M | $1.34B | $672.00M |
| Diluted EPS | 0.40 | 0.61 | 0.90 | 0.45 |
| Operating cash flow | $1.05B | $1.47B | $348.00M | $1.36B |
| Assets | $45.46B | $45.22B | $44.35B | $43.67B |
| Liabilities | $19.59B | $20.04B | $18.25B | $19.20B |
| Equity | $25.87B | $25.17B | $26.10B | $24.47B |
Technicals
Massive · Nov 12, 2026- 50-day average44.06
- 200-day average54.38
- RSI (14 days)49.8
Short interest
Massive · Oct 30, 2026- Oct 30, 202635.11M shares · 1.6 days to cover
- Oct 15, 202640.71M shares · 2.6 days to cover
- Sep 30, 202641.41M shares · 1.9 days to cover
- Sep 15, 202646.50M shares · 2.4 days to cover
Splits
Massive · Nov 6, 2003- Nov 6, 20032-for-1
Related companies
MassiveNews coverage
No stories about Boston Scientific Corp. right now.